Manufacturer programs, insurance strategies, tax tricks, and compounded alternatives — all in one place.
New oral tablet, self-pay patients. 1.5mg and 4mg doses. Through NovoCare Pharmacy.
New patients starting on 0.25mg or 0.5mg. First 2 monthly fills only. Through NovoCare.
For commercially insured patients with coverage. Maximum savings of $100/month, up to 48 months.
Eli Lilly direct program. Single-dose vials for all dose levels. KwikPen $449/mo for 7.5–15mg.
Medicare will cover anti-obesity medications through Part D starting July 2026 with a $50/mo copay cap.
Compounded medications are not FDA-approved. They are custom-made by licensed pharmacies and are available for patients who meet eligibility criteria. Prices below reflect publicly available data as of March 2026.
GLP-1 medications prescribed for a medical condition (obesity, diabetes, PCOS) are typically eligible for HSA and FSA reimbursement. This can save you 22–37% depending on your tax bracket.
Paying $200/mo with HSA in the 24% tax bracket saves $576/year in taxes alone.
Both compounded and brand-name GLP-1 prescriptions generally qualify. Check with your HSA/FSA administrator to confirm eligibility for your specific plan.